| Literature DB >> 35967012 |
Qosimjon Khalilov1,2,3, Sodik Numonov1,2,4, Parviz Sukhrobov1,3, Khayrulla Bobakulov5, Farukh Sharopov1,2, Madina Habasi1, Jiangyu Zhao1,3, Tao Yuan1, Haji Akber Aisa1,3.
Abstract
Laetiporus sulphureus is a popular medicinal mushroom with diverse pharmacological activities in many Asian countries. Four new triterpenoids, named sulphurenoids A-D (1-4), along with 12 known analogues, were isolated from the fruits of L. sulphureus. Nuclear magnetic resonance, infrared spectroscopy, and high-resolution electrospray ionization mass spectrometry (HR-ESI-MS) techniques were used for the investigation of the chemical structure of isolated compounds. In addition, the anti-inflammatory activity of three new compounds (2-4) was tested for NO production in lipopolysaccharide-induced RAW 264.7 cells. The IC50 values of isolated triterpenoids ranged from 14.3 to 42.3 μM, which were more effective than the positive control (IC50 for minocycline was 73.0 μM). The experimentally obtained anti-inflammatory activity data of L. sulphureus are in agreement with its traditional use.Entities:
Year: 2022 PMID: 35967012 PMCID: PMC9366770 DOI: 10.1021/acsomega.2c02165
Source DB: PubMed Journal: ACS Omega ISSN: 2470-1343
1H and 13C NMR Data for Compounds 1–3 (in CD3OD) and 4 (in C5D5N)
| position | ||||||||
|---|---|---|---|---|---|---|---|---|
| δH ( | δC | δH ( | δC | δH ( | δC | δH ( | δC | |
| 1 | 1.99, m | 37.3 | 1.88, m | 38.0 | 1.71, m | 37.1 | 1.62, m | 36.9 |
| 1.38, m | 1.56, m | 1.19, m | 2.14, m | |||||
| 2 | 1.65, m (2H) | 28.6 | 2.30, m | 37.9 | 1.59, m (2H) | 28.6 | 2.24, m | 35.3 |
| 2.23, m | 2.36, m | |||||||
| 3 | 3.15, dd (10.5, 5.3) | 79.7 | 219.2 | 3.13, dd (9.1, 7.2) | 79.8 | 215.6 | ||
| 4 | 39.9 | 48.6 | 40.1 | 47.8 | ||||
| 5 | 1.05, m | 50.7 | 1.51, m | 52.3 | 1.01, dd (12.7, 1.7) | 52.0 | 1.67, m | 51.3 |
| 6 | 2.09, m (2H) | 24.2 | 2.20, m | 24.8 | 1.72, m | 19.6 | 2.14, m | 24.3 |
| 2.09, m | 1.52, m | 2.05, m | ||||||
| 7 | 5.91, d (6.5) | 123.0 | 5.95, d (6.6) | 122.6 | 2.18, m (2H) | 28.3 | 6.47, | 122.1 |
| 8 | 142.4 | 142.6 | 135.5 | 142.4 | ||||
| 9 | 147.8 | 146.4 | 136.3 | 145.7 | ||||
| 10 | 38.8 | 38.7 | 38.5 | 37.9 | ||||
| 11 | 5.32, d (6.3) | 117.1 | 5.43, d (6.4) | 118.2 | 1.98, m (2H) | 21.8 | 5.36, | 117.7 |
| 12 | 2.21, m | 37.5 | 2.20, m | 37.5 | 1.74, m | 30.8 | 2.21, m | 37.3 |
| 1.80, m | 1.82, m | 1.37, m | 1.80, m | |||||
| 13 | 45.4 | 45.4 | 46.1 | 45.2 | ||||
| 14 | 53.0 | 53.0 | 52.7 | 52.7 | ||||
| 15 | 4.24, dd (9.6, 5.7) | 75.0 | 4.26, dd (9.7, 5.8) | 75.0 | 4.18, dd (9.6, 5.7) | 73.9 | 4.78, dd (9.6, 5.8) | 74.1 |
| 16 | 1.99, m | 39.2 | 1.94, m | 39.2 | 1.91, m | 38.9 | 2.24, m | 35.3 |
| 1.78, m | 1.80, m | 1.74, m | 2.36, m | |||||
| 17 | 2.18, m | 47.1 | 2.19, m | 47.1 | 2.14, m | 47.3 | 2.76, m | 46.5 |
| 18 | 0.68, s | 16.9 | 0.72, s | 16.9 | 0.82, s | 17.0 | 1.14, s | 17.2 |
| 19 | 0.99, s | 23.4 | 1.21, s | 22.6 | 1.00, s | 19.7 | 1.16, s | 22.5 |
| 20 | 2.16, m | 49.0 | 2.17, m | 49.0 | 2.14, m | 48.9 | 2.67, m | 49.1 |
| 21 | 180.2 | 180.2 | 180.4 | 179.1 | ||||
| 22 | 1.53, m | 31.5 | 1.54, m | 31.5 | 1.52, m | 31.5 | 2.33, m | 27.1 |
| 1.38, m | 1.38, m | 1.40, m | ||||||
| 23 | 1.60, m | 29.9 | 1.60, m | 29.9 | 1.58, m | 29.8 | 1.81, m | 33.7 |
| 1.46, m | 1.46, m | 1.43, m | ||||||
| 24 | 3.52, | 62.7 | 3.52, | 62.7 | 3.51, | 62.8 | 5.31, | 125.1 |
| 25 | 132.1 | |||||||
| 26 | 1.62, s | 18.1 | ||||||
| 27 | 1.66, s | 26.2 | ||||||
| 28 | 0.98, s | 29.0 | 1.06, s | 26.0 | 0.98, s | 28.8 | 1.06, s | 22.7 |
| 29 | 0.87, s | 16.6 | 1.13, s | 23.0 | 0.80, s | 16.3 | 1.12, s | 26.0 |
| 30 | 0.93, s | 18.1 | 0.93, s | 18.0 | 0.93, s | 17.9 | 1.41, s | 18.5 |
Figure 1(a) Key 1H-1H COSY (—) and selected HMBC correlations (H → C) of 1; (b) selected NOESY correlations (H ↔ H) of 1.
Figure 2Chemical structures of isolated compounds from Laetiporus sulphureus.
Anti-Inflammatory Activities against NO Release in LPS-Induced RAW 264.7 Cells
| No. | name of compounds | IC50 inhibition ratio (μM) |
|---|---|---|
| 1 | sulphurenoid A ( | no effect |
| 2 | sulphurenoid
B ( | 14.3 ± 0.9 |
| 3 | sulphurenoid C ( | 30.2 ± 1.6 |
| 4 | sulphurenoid D ( | 42.3 ± 4.0 |
| minocycline (positive control) | 73.0 ± 2.5 | |